“Popular Blood Pressure Drug Linked to Increased Cardiac Arrest Risk” — What’s the Story?
This headline refers to nifedipine, a calcium-channel blocker used to treat high blood pressure and angina. A study presented at the European Heart Rhythm Association meeting reported an association between high-dose, short-acting nifedipine and out-of-hospital cardiac arrest. Importantly, this was an association, not proof that nifedipine causes cardiac arrest.
D
DailyHealthPost
What you should know
The concern was primarily with high doses of nifedipine, rather than every nifedipine prescription.
The study reportedly did not find the same association with amlodipine, another calcium-channel blocker.
D
DailyHealthPost
A medication being associated with a higher risk in one observational study doesn’t mean everyone taking it is in danger. The underlying heart condition, dose, formulation, and other medications all matter.
Do not stop nifedipine suddenly without speaking with your prescriber. Uncontrolled blood pressure or angina can itself be dangerous.
What about metoprolol?
Since you’ve asked about metoprolol before, it’s worth distinguishing the two. Metoprolol is a beta blocker, not nifedipine. Its prescribing information does warn that severe bradycardia, heart block, and cardiac arrest have occurred, particularly in susceptible patients—but that doesn’t mean routine therapeutic use commonly causes cardiac arrest.
D
DailyMed
Bottom line: The headline is based on a real safety signal involving high-dose nifedipine, but it’s too broad to conclude that “nifedipine causes cardiac arrest.” If you’re taking nifedipine, the sensible step is to have your exact dose and formulation reviewed by your doctor or pharmacist rather than stopping it yourself.
D
D
Sources
